MicroRNA signature in patients with hepatocellular carcinoma associated with type 2 diabetes

Abstract

This study validates a panel of serum miRNAs that can be used as a reliable noninvasive screening biomarker of HCC among T2DM cirrhotic and noncirrhotic patients. The study recommends further research to shed light on a possible role of c-Met in T2DM-associated HCC <i>via</i> the miRNA regulatory pathway.